BLSA
BCLS Acquisition Corp
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
| Actual EPS |
|---|
| Consensus EPS |
| Estimated EPS |
| Number of Estimates |
| EPS Surprise |
Stats
Summary
BCLS Acquisition Corp. is a special purpose acquisition company formed for the purpose of entering into a combination with one or more businesses or entities. While the Company may pursue an acquisition opportunity in any business, industry, sector or geographical location, it intends to pursue investments, primarily based in North America and Europe and selectively in other geographies, including Asia and emerging markets, in biopharmaceutical, specialty pharmaceutical, medical device, diagnostics and enabling life science technology companies. The Company is sponsored by an affiliate of Bain Capital Life Sciences, a leading life sciences investment manager.
Market Cap: 149 Million
Primary Exchange: NASDAQ
Website: bclsacquisitioncorp.com
Shares Outstanding: 14.9 Million
Float: 0
Dividend: 0.0 (0.0%)
Beta: 0.0
Sector:
Industry:
Ethical Flags
Longest drawdown: 604 trading days
From: 2021-02-19 To: 2022-10-26
Lowest Point:
| Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
|---|
| Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
|---|